1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Comparison of Perceptions of Skin Condition, Product Use and Allergen Reactivity Between People with Psoriasis and Controls in the European Dermato-Epidemiology Network (EDEN) Fragrance Study
(
- Contribution to journal › Article
- 2023
-
Mark
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis : Narrative Review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Income disparities in healthcare use remain after controlling for healthcare need : evidence from Swedish register data on psoriasis and psoriatic arthritis
(
- Contribution to journal › Article
- 2010
-
Mark
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006
(
- Contribution to journal › Article
- 2006
-
Mark
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet (R)/Dovobet (R)/Taclonex (R)) in the treatment of psoriasis vulgaris
(
- Contribution to journal › Article
-
Mark
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet((R))/Daivobet((R))/Taclonex((R))) in the treatment of psoriasis vulgaris
(
- Contribution to journal › Article